147 related articles for article (PubMed ID: 10663390)
1. Non-N-methyl-D-aspartate (NMDA) receptor antagonist 1,2,3, 4-tetrahydro-6-nitro-2,3-dioxo-benzo(f)quinoxaline-7-sulphonamide (NBQX) decreases functional disorders in cytotoxic brain oedema.
Häntzschel A; Andreas K
Arch Toxicol; 2000 Jan; 73(10-11):581-7. PubMed ID: 10663390
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of glutamate receptor antagonists in the management of functional disorders in cytotoxic brain oedema induced by hexachlorophene.
Häntzschel A; Andreas K
Pharmacol Toxicol; 1998 Feb; 82(2):80-8. PubMed ID: 9498236
[TBL] [Abstract][Full Text] [Related]
3. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.
Kohara A; Okada M; Tsutsumi R; Ohno K; Takahashi M; Shimizu-Sasamata M; Shishikura J; Inami H; Sakamoto S; Yamaguchi T
J Pharm Pharmacol; 1998 Jul; 50(7):795-801. PubMed ID: 9720630
[TBL] [Abstract][Full Text] [Related]
4. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
[TBL] [Abstract][Full Text] [Related]
5. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism.
Kanellopoulos GK; Xu XM; Hsu CY; Lu X; Sundt TM; Kouchoukos NT
Stroke; 2000 Aug; 31(8):1945-52. PubMed ID: 10926962
[TBL] [Abstract][Full Text] [Related]
6. Effects of AMPA/kainate glutamate receptor antagonists on cocaine-induced convulsions and lethality in mice.
Pouw B; Nour M; Matsumoto RR
Eur J Pharmacol; 1999 Dec; 386(2-3):181-6. PubMed ID: 10618468
[TBL] [Abstract][Full Text] [Related]
7. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
Parsons CG; Gruner R; Rozental J
Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
[TBL] [Abstract][Full Text] [Related]
8. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
9. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
[TBL] [Abstract][Full Text] [Related]
10. Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA- and AMPA receptor antagonists.
Berg M; Bruhn T; Johansen FF; Diemer NH
Pharmacol Toxicol; 1993 Nov; 73(5):262-8. PubMed ID: 8115308
[TBL] [Abstract][Full Text] [Related]
11. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
12. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors.
Christoffersen CL; Meltzer LT
Neuroscience; 1995 Jul; 67(2):373-81. PubMed ID: 7545793
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of cerebroprotective substances in the management of functional disorders induced by the cytotoxic brain oedema-producing substance hexachlorophene.
Andreas K
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):79-83. PubMed ID: 8446185
[TBL] [Abstract][Full Text] [Related]
15. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
Prehn JH; Lippert K; Krieglstein J
Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.
Maranis S; Stamatis D; Tsironis C; Konitsiotis S
Eur J Pharmacol; 2012 May; 683(1-3):71-7. PubMed ID: 22410193
[TBL] [Abstract][Full Text] [Related]
17. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
18. NBQX, an improved non-NMDA antagonist studied in retinal ganglion cells.
Yu W; Miller RF
Brain Res; 1995 Sep; 692(1-2):190-4. PubMed ID: 8548303
[TBL] [Abstract][Full Text] [Related]
19. Regulation of growth hormone secretion by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in infantile, prepubertal, and adult male rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
Endocrinology; 1999 Mar; 140(3):1279-84. PubMed ID: 10067854
[TBL] [Abstract][Full Text] [Related]
20. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
Ruiz A; Durand J
Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
